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1. Decreased insulin secretion in first-degree family members
of NIDDM patients. T.W. van Haeften1, S. Dubbeldam2, M.L.
Zonderland2, D.W. Erkelens1. Departments of internal Medicine 
2
and Physiology, Utrecht University, Utrecht, Netherlands.
Insulin secretion and insulin sensitivity were assessed in 20 
first-degree NIDDM family members and compared with 20 
controls matched for gender, body mass index, waist/hip ratio, 
and aerobic capacity (Vo2max). All subjects had a normal glucose 
tolerance (OGTT, 75 g glucose), Vo2Max was assessed by en­
durance exercise-test on a bicycle ergometer. A hyperglycemic 
clamp (10 mmol/1, 180 min) was performed. Glucose infusion 
rates (GIR) during the second and third hour of the clamp were 
measured; the relation between GIR and mean plasma insulin was 
used for assessment of insulin sensitivity. First-phase insulin 
secretion (plasma insulin 0—10 min, logarithmic transformation) 
showed a trend towards lower values in NIDDM family members 
(MANOVA, P — 0.091). Second-phase insulin secretion (2nd and 
3rd hour) was lower in family members (MANOVA, P — 0.042). 
ANOVA showed lower insulin levels at all time-points after 100 
min (all P < 0.05); at 180 min the geometric mean was 56 (range 
27-152) vs 79 (range 32-230) mU/L  GIR of 2nd and 3rd hour 
were significantly lower in family members (5.7 ±2.4 vs 8.3 ±3.4, 
and 8.3±3.7 vs 12.0 + 4.0 mg/kg/min, both JP<0.01). After 
correction for the mean insulin level, insulin sensitivity (2nd and 
3rd hour) was not significantly different (0,140 + 0.054 vs 0.165 ± 
0.075; and 0.165 ±0.066 vs 0.180 ±0.087 m g/kg/m in/m U /1, 
both P > 0.20).
Conclusions: Glucose-tolerant first-degree NIDDM family 
members have decreased insulin secretion as compared to matched 
controls; their insulin sensitivity does not appear to be markedly 
decreased.
2. Euglycemic-hyperinsulinemic clamp in healthy volunteers
and insulin-resistant obese subjects monitored with in vivo
13C-MR spectroscopy. A.J. van den Bergh1, CJ.J. Tack2, P.
if 2Smits3, A. Heerschap1. Departments of Radiology, Internal
j
Medicine and Pharmacology, University Hospital, Nijmegen, 
Netherlands.
Insulin resistance is a prominent common pathogenetic trait of 
disorders such as non-insulin-dependent diabetes mellitus. It has 
been shown previously that under conditions of insulin resistance, 
glucose uptake in skeletal muscle is decreased as is glycogenesis. 
The rate of glycogen formation in response to insulin, however, is 
difficult to assess, and requires sequential muscle biopsies. 13C-MR 
spectroscopy offers an attractive non-invasive alternative. In 2 
male insulin-sensitive healthy volunteers (age 23 and 27 yr, body 
mass index (BMI) 23.3 and 22.4 kg m~2, glucose infusion rate 
(GIR) 14.0 and 16.1 mg kg-1 min~ *, and 2 male insulin-resistant 
obese subjects (age 28 and 39 yr, BMI 31.0 and 33.6 kg m"2, 
GIR 6,32 and 5.37 mg kg"1 min” 1) hyperinsulinemic (60 mU 
m -2 min- i ) euglycemic clamps with infusion of glucose 20% 
solution (30% enriched with [l-13C]glucose) were combined with 
l3C-MR-spectroscopy of the gastrocnemius muscle. Proton-decou- 
pled UC-MR spectra were acquired with a time resolution of 15 
min. Signals of creatine, glycogen and glucose were analyzed. 
Glycogen concentrations were calculated using creatine as an 
internal concentration standard. Plasma glucose enrichment levels 
were measured using high-resolution NMR. Resonances from 
glycogen and the glucose anomers were clearly visible. During the 
clamp glucose levels in spectra showed a steady state within 60 
min after infusion. A strong linear increase was observed in 
[13C]glycogen formation until the end of glucose infusion. 
Insulin-resistant subjects showed a much slower glucose incorpo­
ration rate in glycogen than the insulin-sensitive subjects (10.5 
and 19.4 mM/h for the insulin-sensitive subjects, 4.3 and 3.9 
mM /h for the insulin-resistant subjects, respectively).
Conclusion: l3C-MR spectroscopy in combination with eug­
lycemic hyperinsulinemic clamping with infusion of I3C~enriched 
glucose offers a powerful tool to study glucose metabolism in 
vivo.
3. Effects of acarbose on glycaemic control in subjects with 
IDDM. J.P.J.E. Sels1, H.E.R. Verdonk2, B.H.R. Wolffenbuttel1, 
on behalf of the Dutch IDDM Acarbose Study Group. JDepart- 
ment of Endocrinology, University Hospital Maastricht; Bayer 
NV, Mijdrecht, Netherlands.
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